Use of Replication-Defective Adenoviruses to Develop Vaccines and Biotherapeutics Against Foot-and-Mouth Disease
Authors:
- 24 August 2012
- journal article
- review article
- Published by Taylor & Francis in Future Virology
- Vol. 7 (8) , 767-778
Abstract
No abstract availableKeywords
Funding Information
- CRIS
- Agricultural Research Service
- USDA
- US Department of Homeland Security (HSHQPD-07-X-00003, HSHQDC-09-X-00373, HSHQDC-11-X-00189)
- National Pork Board (#11-005, #12-023)
This publication has 80 references indexed in Scilit:
- An Epidemiological Analysis of the Foot-and-Mouth Disease Epidemic in Miyazaki, Japan, 2010Transboundary and Emerging Diseases, 2010
- Adenovirus Serotype 5-Vectored Foot-And-Mouth Disease Subunit Vaccines: The First DecadeFuture Virology, 2009
- Foot-and-Mouth DiseaseClinical Microbiology Reviews, 2004
- Evolution of foot-and-mouth disease virusVirus Research, 2003
- Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001Scientific and Technical Review, 2002
- Control of foot and mouth disease: lessons from the experience of the outbreak in Great Britain in 2001Scientific and Technical Review, 2002
- Aspects of the persistence of foot-and-mouth disease virus in animals—the carrier problemMicrobes and Infection, 2002
- Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24Vaccine, 2002
- Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructsVaccine, 2001
- Development of Replication-Defective Adenovirus Serotype 5 Containing the Capsid and 3C Protease Coding Regions of Foot-and-Mouth Disease Virus as a Vaccine CandidateVirology, 1999